期刊文献+

胰腺癌基础研究现状和展望 被引量:8

State of the art of Imsic research in pancreatic cancer
原文传递
导出
摘要 胰腺癌是一种发病隐匿、进展迅速、预后极差的消化道恶性肿瘤,5年生存率在5%~7%之间。20年来,胰腺癌临床治疗效果并没有取得实质性进步。在临床方面无法取得突破的情况下,针对胰腺癌领域难点、热点问题,加强相关的基础研究显得尤为重要。不断探索基础研究成果向临床应用的转化,从而提高治疗效果,延长患者生存时间,最终攻克这一世界性难题。本文主要阐述近年来胰腺癌基础研究现状、进展以及展望,希望藉此梳理出胰腺癌新的诊疗策略。 Pancreatic cancer is a malignant tumor of the digestive system, whose clinical symptom is insidious, progression is quick and prognosis is worst, and the five - year survival rate is about 5% - 7%. From the past twenty years, the clinical treatment of pancreatic cancer has not made substantial progress. It is important to strengthen the basic research targeting the difficulties and hot issues in the field of pancreatic cancer. In order to finally overcome this worldwide problem, it is important to explore the transformation of basic research results to clinical practice for improving the treatment effect and prolonging the survival time of patients. This paper mainly describes the current situation, progress and prospect of pancreatic cancer, hoping to find out a new diagnosis and treatment strategy of pancreatic cancer.
作者 袁达 郭俊超
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2016年第1期4-6,共3页 Chinese Journal of Experimental Surgery
关键词 胰腺癌 诊断 治疗 Pancreatic cancer Diagnosis Treatment
  • 相关文献

参考文献18

  • 1Siegel R, Ma J, Zou Z, et al. Cancer statistics,2014 [ J ]. CA Cancer J Clin ,2014,64( 1 ) :9-29. DOI: 10. 3322/caac. 21208.
  • 2Zheng RS, Zeng HM, Zhang SW, et al. National estimates of cancer prevalence in China[ J]. Cancer Lett ,2016,370 ( 1 ) :33-38. DOI : 10. 1016/j. canlet. 2015.10.003.
  • 3Cooper CL, O' Toole SA, Keneh JG. Classification, morphology and molecular pathology of premaligaant lesions of the pancreas [ J ]. Pa- thology ,2013,45 (3) :286-304. DOI : 10. 1097/PAT. 0b013e32835f2205.
  • 4Yachida S, Jones S, Bozic I, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer [ J ]. Nature, 2010, 467 (7319) :1114-1117. DOI : 10. 1038/nature09515.
  • 5Bockman DE, Guo JC, Peter B, et al. Origin and development of the precursor lesions in experimental pancreatic cancer in rats [ J ]. Lab Invest ,2003,83 (6) :853-859. DOI:IO. 1097/01. LAB. 0000074918. 31303.5A.
  • 6Guo JC, Li J, Yang YC, et al. Oligonucleotide microarray identifies genes differentially expressed during tumorigenesis of DMBA-induced pancreatic cancer in rats [J]. PLoS One, 2013,8 ( 12 ) : e82910- e82910. DOI : 10. 1371/joumal. pone. 0082910.
  • 7Jones S, Zhang X, Parsons DW, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses [ J ].Seienee ,2008,321 ( 5897 ) : 1801-1806. DOI : 10.1126/science. 1164368.
  • 8Real FX, Elena CU, Paola M. Pancreatic cancer development and pro- gression : remodeling the model [ J ]. Gastroenterology, 2008,135 ( 3 ) : 724-728. DOI : 10. 1053/j. gastro. 2008.07. 033.
  • 9Miehael XL, Muhammad WS. Screening for early pancreatic ductal ad- an urgent call~ J ]. JOP,2009,10 ( 2 ) : 104-108.
  • 10Gold DV,Modrak DE,Ying Z,et al. New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis [ J ]. J 'Clin Oncol, 2006,24(2) :252-258. DOI : 10. 1200/JCO. 2005.02. 8282.

同被引文献49

引证文献8

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部